The Trustees of The University of Pennsylvania;Novartis AG
发明人:
申请号：
EP19169356.3
公开号：
EP3593812A2
申请日:
2015.03.13
申请国别(地区):
EP
年份:
2020
代理人:
摘要：
The invention provides compositions and methods for treating diseases associated with expression of a cancer associated antigen as described herein. The invention also relates to chimeric antigen receptor (CAR) specific to a cancer associated antigen as described herein, vectors encoding the same, and recombinant T cells comprising the CARs of the present invention. The invention also includes methods of administering a genetically modified T cell expressing a CAR that comprises an antigen binding domain that binds to a cancer associated antigen as described herein.
